AVIDITY PARTNERS MANAGEMENT LP Holdings

AVIDITY PARTNERS MANAGEMENT LP is an investment fund managing more than 4.92B US dollars. The largest holdings include Eli Lilly and Company, SPDR SER TR and United Therapeutics. In Q3 2022 the fund bought assets of total value of 1.71B US dollars and sold assets of total value of 1.46B US dollars.

$4.91B

portfolio value

-3.15%

quarter

-30.40%

1 year

AVIDITY PARTNERS MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	599875000	69412000
Q2 2020	1204458000	338044000
Q3 2020	1133141000	805475000
Q4 2020	1926439000	811712000
Q1 2021	1495133000	901807000
Q2 2021	1371366000	1233790000
Q3 2021	1300574000	1056195000
Q4 2021	1446662000	631963000
Q1 2022	1028664000	1065239000
Q2 2022	1323030000	1404589000
Q3 2022	1707702000	1460148000

AVIDITY PARTNERS MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 6.62% Portfolio value: 325.61M Avg. open price: $320.85 Current price: $369.29 P/L: +15.10% Bought +65.08% shares Q3 2022	share	6.62%	325.61M	$320.85	$369.29	+15.10%	Bought +65.08% shares Q3 2022
SPDR SER TR Portfolio share: 6.53% Portfolio value: 321.40M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	call	6.53%	321.40M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 4.13% Portfolio value: 203.14M Avg. open price: $208.42 Current price: $273.72 P/L: +31.33% Bought +33.71% shares Q3 2022	share	4.13%	203.14M	$208.42	$273.72	+31.33%	Bought +33.71% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 4.01% Portfolio value: 197.09M Avg. open price: $96.09 Current price: $124 P/L: +29.05% Bought +26.44% shares Q3 2022	share	4.01%	197.09M	$96.09	$124	+29.05%	Bought +26.44% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 3.93% Portfolio value: 193.24M Avg. open price: $55.02 Current price: $39.53 P/L: -28.15% Bought +29.44% shares Q3 2022	share	3.93%	193.24M	$55.02	$39.53	-28.15%	Bought +29.44% shares Q3 2022
Biotechnology argenx SE Portfolio share: 3.53% Portfolio value: 173.63M Avg. open price: $315.31 Current price: $393.21 P/L: +24.70% Sold -14.10% shares Q3 2022	share	3.53%	173.63M	$315.31	$393.21	+24.70%	Sold -14.10% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 3.26% Portfolio value: 160.2M Avg. open price: $215.89 Current price: $292.75 P/L: +35.60% Bought +36.19% shares Q3 2022	share	3.26%	160.2M	$215.89	$292.75	+35.60%	Bought +36.19% shares Q3 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 3.02% Portfolio value: 148.47M Avg. open price: $227.75 Current price: $317.6 P/L: +39.45% Sold -35.33% shares Q3 2022	share	3.02%	148.47M	$227.75	$317.6	+39.45%	Sold -35.33% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 2.73% Portfolio value: 134.25M Avg. open price: $17.88 Current price: $25.44 P/L: +42.32% Bought +2.51% shares Q3 2022	share	2.73%	134.25M	$17.88	$25.44	+42.32%	Bought +2.51% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 2.42% Portfolio value: 119.25M Avg. open price: N/A Current price: $60.39 P/L: N/A N/A Q3 2022	share	2.42%	119.25M	N/A	$60.39	N/A	N/A Q3 2022
SPDR S&P Biotech ETF Portfolio share: 2.39% Portfolio value: 117.39M Avg. open price: $89.88 Current price: $82.88 P/L: -7.79% Sold -21.07% shares Q3 2022	share	2.39%	117.39M	$89.88	$82.88	-7.79%	Sold -21.07% shares Q3 2022
Medical Care Facilities Acadia Healthcare Company, Inc. Portfolio share: 2.21% Portfolio value: 108.60M Avg. open price: $67.63 Current price: $85.65 P/L: +26.64% Bought +34.22% shares Q3 2022	share	2.21%	108.60M	$67.63	$85.65	+26.64%	Bought +34.22% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 2.16% Portfolio value: 106.30M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	2.16%	106.30M	N/A	$44.04	N/A	N/A Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 2.13% Portfolio value: 104.81M Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q3 2022	share	2.13%	104.81M	N/A	$122.96	N/A	N/A Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 2.09% Portfolio value: 102.86M Avg. open price: $435.17 Current price: $547.42 P/L: +25.79% Sold -48.58% shares Q3 2022	share	2.09%	102.86M	$435.17	$547.42	+25.79%	Sold -48.58% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 2.00% Portfolio value: 98.32M Avg. open price: $44.22 Current price: $45.42 P/L: +2.72% Bought +0.54% shares Q3 2022	share	2.00%	98.32M	$44.22	$45.42	+2.72%	Bought +0.54% shares Q3 2022
Biotechnology Immunocore Holdings plc Portfolio share: 1.98% Portfolio value: 97.59M Avg. open price: $37.74 Current price: $58.07 P/L: +53.86% Bought +54.01% shares Q3 2022	share	1.98%	97.59M	$37.74	$58.07	+53.86%	Bought +54.01% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 1.97% Portfolio value: 97.12M Avg. open price: $126.51 Current price: $226.95 P/L: +79.39% Bought +111.08% shares Q3 2022	share	1.97%	97.12M	$126.51	$226.95	+79.39%	Bought +111.08% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 1.92% Portfolio value: 94.3M Avg. open price: $491.22 Current price: $522.34 P/L: +6.34% Sold -52.93% shares Q3 2022	share	1.92%	94.3M	$491.22	$522.34	+6.34%	Sold -52.93% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.86% Portfolio value: 91.73M Avg. open price: $80.97 Current price: $98.48 P/L: +21.62% Sold -20.18% shares Q3 2022	share	1.86%	91.73M	$80.97	$98.48	+21.62%	Sold -20.18% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 1.86% Portfolio value: 91.47M Avg. open price: $48.36 Current price: $20.26 P/L: -58.11% Bought +17.77% shares Q3 2022	share	1.86%	91.47M	$48.36	$20.26	-58.11%	Bought +17.77% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 1.80% Portfolio value: 88.64M Avg. open price: $27.4 Current price: $22.35 P/L: -18.43% Sold -32.02% shares Q3 2022	share	1.80%	88.64M	$27.4	$22.35	-18.43%	Sold -32.02% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 1.73% Portfolio value: 84.95M Avg. open price: $71.9 Current price: $39.83 P/L: -44.61% Bought +38.67% shares Q3 2022	share	1.73%	84.95M	$71.9	$39.83	-44.61%	Bought +38.67% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 1.55% Portfolio value: 76.02M Avg. open price: $82.13 Current price: $40.39 P/L: -50.82% Bought +26.73% shares Q3 2022	share	1.55%	76.02M	$82.13	$40.39	-50.82%	Bought +26.73% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 1.40% Portfolio value: 68.65M Avg. open price: $58.83 Current price: $77.29 P/L: +31.38% N/A Q3 2022	share	1.40%	68.65M	$58.83	$77.29	+31.38%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 1.38% Portfolio value: 68.01M Avg. open price: $100.79 Current price: $50.77 P/L: -49.63% Sold -1.57% shares Q3 2022	share	1.38%	68.01M	$100.79	$50.77	-49.63%	Sold -1.57% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 1.33% Portfolio value: 65.25M Avg. open price: $57.08 Current price: $54.25 P/L: -4.96% Bought +80.85% shares Q3 2022	share	1.33%	65.25M	$57.08	$54.25	-4.96%	Bought +80.85% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 1.24% Portfolio value: 60.95M Avg. open price: $155.47 Current price: $121.22 P/L: -22.03% Sold -19.00% shares Q3 2022	share	1.24%	60.95M	$155.47	$121.22	-22.03%	Sold -19.00% shares Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 1.23% Portfolio value: 60.40M Avg. open price: N/A Current price: $405.79 P/L: N/A N/A Q3 2022	share	1.23%	60.40M	N/A	$405.79	N/A	N/A Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 1.17% Portfolio value: 57.74M Avg. open price: $169.52 Current price: $226.4 P/L: +33.55% N/A Q3 2022	share	1.17%	57.74M	$169.52	$226.4	+33.55%	N/A Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 1.17% Portfolio value: 57.64M Avg. open price: $42.37 Current price: $49.41 P/L: +16.62% Bought +292.56% shares Q3 2022	share	1.17%	57.64M	$42.37	$49.41	+16.62%	Bought +292.56% shares Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 1.14% Portfolio value: 55.91M Avg. open price: $72.67 Current price: $42.01 P/L: -42.19% Sold -11.21% shares Q3 2022	share	1.14%	55.91M	$72.67	$42.01	-42.19%	Sold -11.21% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 1.13% Portfolio value: 55.43M Avg. open price: $18.43 Current price: $17.77 P/L: -3.58% Bought +24.97% shares Q3 2022	share	1.13%	55.43M	$18.43	$17.77	-3.58%	Bought +24.97% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.95% Portfolio value: 46.61M Avg. open price: $9.8 Current price: $7.07 P/L: -27.85% Bought +33.69% shares Q3 2022	share	0.95%	46.61M	$9.8	$7.07	-27.85%	Bought +33.69% shares Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 0.93% Portfolio value: 45.90M Avg. open price: $4.2 Current price: $10.02 P/L: +138.79% Bought +1.92% shares Q3 2022	share	0.93%	45.90M	$4.2	$10.02	+138.79%	Bought +1.92% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 0.93% Portfolio value: 45.77M Avg. open price: $19.49 Current price: $24.32 P/L: +24.78% Bought +75.18% shares Q3 2022	share	0.93%	45.77M	$19.49	$24.32	+24.78%	Bought +75.18% shares Q3 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 0.86% Portfolio value: 42.45M Avg. open price: $18.74 Current price: $11.18 P/L: -40.33% Bought +24.99% shares Q3 2022	share	0.86%	42.45M	$18.74	$11.18	-40.33%	Bought +24.99% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 0.86% Portfolio value: 42.42M Avg. open price: $156.01 Current price: $150.97 P/L: -3.23% Bought +413.39% shares Q3 2022	share	0.86%	42.42M	$156.01	$150.97	-3.23%	Bought +413.39% shares Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.86% Portfolio value: 42.20M Avg. open price: N/A Current price: $33.74 P/L: N/A N/A Q3 2022	share	0.86%	42.20M	N/A	$33.74	N/A	N/A Q3 2022
Biotechnology Arrowhead Pharmaceuticals, Inc. Portfolio share: 0.84% Portfolio value: 41.49M Avg. open price: $65.47 Current price: $31.87 P/L: -51.32% Sold -12.76% shares Q3 2022	share	0.84%	41.49M	$65.47	$31.87	-51.32%	Sold -12.76% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 0.84% Portfolio value: 41.38M Avg. open price: N/A Current price: $17 P/L: N/A N/A Q3 2022	share	0.84%	41.38M	N/A	$17	N/A	N/A Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.77% Portfolio value: 37.66M Avg. open price: N/A Current price: $116.56 P/L: N/A N/A Q3 2022	share	0.77%	37.66M	N/A	$116.56	N/A	N/A Q3 2022
Medical Devices Stryker Corporation Portfolio share: 0.76% Portfolio value: 37.40M Avg. open price: N/A Current price: $237.9 P/L: N/A N/A Q3 2022	share	0.76%	37.40M	N/A	$237.9	N/A	N/A Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.73% Portfolio value: 35.81M Avg. open price: N/A Current price: $21.42 P/L: N/A N/A Q3 2022	share	0.73%	35.81M	N/A	$21.42	N/A	N/A Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.70% Portfolio value: 34.27M Avg. open price: $10.27 Current price: $11.09 P/L: +7.96% Sold -9.96% shares Q3 2022	share	0.70%	34.27M	$10.27	$11.09	+7.96%	Sold -9.96% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 0.68% Portfolio value: 33.64M Avg. open price: N/A Current price: $86.35 P/L: N/A N/A Q3 2022	share	0.68%	33.64M	N/A	$86.35	N/A	N/A Q3 2022
Biotechnology Caribou Biosciences, Inc. Portfolio share: 0.68% Portfolio value: 33.47M Avg. open price: $13.38 Current price: $9.14 P/L: -31.67% Bought +7.55% shares Q3 2022	share	0.68%	33.47M	$13.38	$9.14	-31.67%	Bought +7.55% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.63% Portfolio value: 30.88M Avg. open price: $55.47 Current price: $68.42 P/L: +23.34% Sold -83.90% shares Q3 2022	share	0.63%	30.88M	$55.47	$68.42	+23.34%	Sold -83.90% shares Q3 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.48% Portfolio value: 23.51M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2022	share	0.48%	23.51M	N/A	$5.6	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Deciphera Pharmaceuticals, Inc. Portfolio share: 0.45% Portfolio value: 22.04M Avg. open price: N/A Current price: $15.02 P/L: N/A Sold -0.68% shares Q3 2022	share	0.45%	22.04M	N/A	$15.02	N/A	Sold -0.68% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.44% Portfolio value: 21.79M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2022	share	0.44%	21.79M	N/A	$6.72	N/A	N/A Q3 2022
Biotechnology Phathom Pharmaceuticals, Inc. Portfolio share: 0.43% Portfolio value: 21.12M Avg. open price: $19.46 Current price: $11.07 P/L: -43.11% Sold -0.68% shares Q3 2022	share	0.43%	21.12M	$19.46	$11.07	-43.11%	Sold -0.68% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 0.41% Portfolio value: 20.25M Avg. open price: N/A Current price: $12.5 P/L: N/A N/A Q3 2022	share	0.41%	20.25M	N/A	$12.5	N/A	N/A Q3 2022
Biotechnology Nkarta, Inc. Portfolio share: 0.38% Portfolio value: 18.60M Avg. open price: N/A Current price: $8.15 P/L: N/A N/A Q2 2022	share	0.38%	18.60M	N/A	$8.15	N/A	N/A Q2 2022
Biotechnology BeiGene, Ltd. Portfolio share: 0.36% Portfolio value: 17.79M Avg. open price: N/A Current price: $188.71 P/L: N/A N/A Q3 2022	share	0.36%	17.79M	N/A	$188.71	N/A	N/A Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 0.35% Portfolio value: 17.40M Avg. open price: $27.49 Current price: $12.08 P/L: -56.06% Sold -0.33% shares Q3 2022	share	0.35%	17.40M	$27.49	$12.08	-56.06%	Sold -0.33% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.35% Portfolio value: 17.37M Avg. open price: N/A Current price: $9.29 P/L: N/A N/A Q3 2022	share	0.35%	17.37M	N/A	$9.29	N/A	N/A Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.33% Portfolio value: 16.23M Avg. open price: N/A Current price: $38.12 P/L: N/A N/A Q3 2022	share	0.33%	16.23M	N/A	$38.12	N/A	N/A Q3 2022
Biotechnology Arcutis Biotherapeutics, Inc. Portfolio share: 0.31% Portfolio value: 15.18M Avg. open price: N/A Current price: $17.35 P/L: N/A N/A Q3 2022	share	0.31%	15.18M	N/A	$17.35	N/A	N/A Q3 2022
Biotechnology Vaxcyte, Inc. Portfolio share: 0.31% Portfolio value: 15.08M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q3 2022	share	0.31%	15.08M	N/A	$44.33	N/A	N/A Q3 2022
Medical Devices Alphatec Holdings, Inc. Portfolio share: 0.30% Portfolio value: 14.98M Avg. open price: $15.05 Current price: $9.75 P/L: -35.22% Sold -37.31% shares Q2 2022	share	0.30%	14.98M	$15.05	$9.75	-35.22%	Sold -37.31% shares Q2 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.29% Portfolio value: 14.49M Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q3 2022	share	0.29%	14.49M	N/A	$7.05	N/A	N/A Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 0.27% Portfolio value: 13.24M Avg. open price: $22.14 Current price: $8.03 P/L: -63.73% Sold -0.68% shares Q3 2022	share	0.27%	13.24M	$22.14	$8.03	-63.73%	Sold -0.68% shares Q3 2022
Biotechnology AN2 Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 12.90M Avg. open price: $7.75 Current price: $9.14 P/L: +17.94% Bought +7.89% shares Q3 2022	share	0.26%	12.90M	$7.75	$9.14	+17.94%	Bought +7.89% shares Q3 2022
Biotechnology Century Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 12.89M Avg. open price: $11.9 Current price: $10.25 P/L: -13.86% Bought +50.71% shares Q3 2022	share	0.26%	12.89M	$11.9	$10.25	-13.86%	Bought +50.71% shares Q3 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.25% Portfolio value: 12.52M Avg. open price: N/A Current price: $61.9 P/L: N/A N/A Q3 2022	share	0.25%	12.52M	N/A	$61.9	N/A	N/A Q3 2022
Biotechnology Sangamo Therapeutics, Inc. Portfolio share: 0.24% Portfolio value: 11.56M Avg. open price: N/A Current price: $3.54 P/L: N/A N/A Q3 2022	share	0.24%	11.56M	N/A	$3.54	N/A	N/A Q3 2022
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 11.44M Avg. open price: N/A Current price: $7.16 P/L: N/A N/A Q3 2022	share	0.23%	11.44M	N/A	$7.16	N/A	N/A Q3 2022
Medical Devices SeaSpine Holdings Corporation Portfolio share: 0.23% Portfolio value: 11.41M Avg. open price: $19.85 Current price: $7.67 P/L: -61.36% Bought +3.45% shares Q4 2021	share	0.23%	11.41M	$19.85	$7.67	-61.36%	Bought +3.45% shares Q4 2021
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 0.18% Portfolio value: 8.91M Avg. open price: N/A Current price: $7.06 P/L: N/A N/A Q3 2022	share	0.18%	8.91M	N/A	$7.06	N/A	N/A Q3 2022
Biotechnology Erasca, Inc. Portfolio share: 0.16% Portfolio value: 7.66M Avg. open price: N/A Current price: $7.28 P/L: N/A Sold -1.26% shares Q3 2022	share	0.16%	7.66M	N/A	$7.28	N/A	Sold -1.26% shares Q3 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 0.15% Portfolio value: 7.19M Avg. open price: $9.75 Current price: $6.78 P/L: -30.52% Bought 0.00% shares Q3 2022	share	0.15%	7.19M	$9.75	$6.78	-30.52%	Bought 0.00% shares Q3 2022
Medical Care Facilities Surgery Partners, Inc. Portfolio share: 0.13% Portfolio value: 6.26M Avg. open price: N/A Current price: $28.6 P/L: N/A N/A Q3 2022	share	0.13%	6.26M	N/A	$28.6	N/A	N/A Q3 2022
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.12% Portfolio value: 5.79M Avg. open price: N/A Current price: $3.83 P/L: N/A N/A Q3 2022	share	0.12%	5.79M	N/A	$3.83	N/A	N/A Q3 2022
Health Information Services CareMax, Inc. Portfolio share: 0.11% Portfolio value: 5.35M Avg. open price: $12.9 Current price: $3.49 P/L: -72.95% Sold -8.71% shares Q1 2022	share	0.11%	5.35M	$12.9	$3.49	-72.95%	Sold -8.71% shares Q1 2022
Shell Companies Medicus Sciences Acquisition Corp. Portfolio share: 0.10% Portfolio value: 5.14M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q2 2021	share	0.10%	5.14M	N/A	$10	N/A	N/A Q2 2021
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.10% Portfolio value: 5.01M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.10%	5.01M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology Graphite Bio, Inc. Portfolio share: 0.10% Portfolio value: 4.99M Avg. open price: $3.18 Current price: $3.59 P/L: +12.90% Bought +121.83% shares Q3 2022	share	0.10%	4.99M	$3.18	$3.59	+12.90%	Bought +121.83% shares Q3 2022
Shell Companies ARYA Sciences Acquisition Corp IV Portfolio share: 0.10% Portfolio value: 4.95M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q1 2021	share	0.10%	4.95M	N/A	$10.05	N/A	N/A Q1 2021
Shell Companies Panacea Acquisition Corp. II Portfolio share: 0.10% Portfolio value: 4.9M Avg. open price: N/A Current price: $9.93 P/L: N/A N/A Q2 2021	share	0.10%	4.9M	N/A	$9.93	N/A	N/A Q2 2021
Biotechnology Compass Therapeutics, Inc. Portfolio share: 0.09% Portfolio value: 4.56M Avg. open price: N/A Current price: $4.53 P/L: N/A N/A Q4 2021	share	0.09%	4.56M	N/A	$4.53	N/A	N/A Q4 2021
Biotechnology ESSA Pharma Inc. Portfolio share: 0.09% Portfolio value: 4.47M Avg. open price: $8.78 Current price: $3.47 P/L: -60.46% Bought +0.41% shares Q4 2021	share	0.09%	4.47M	$8.78	$3.47	-60.46%	Bought +0.41% shares Q4 2021
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.08% Portfolio value: 3.96M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2020	share	0.08%	3.96M	N/A	$9.96	N/A	N/A Q3 2020
Biotechnology Cyteir Therapeutics, Inc. Portfolio share: 0.07% Portfolio value: 3.46M Avg. open price: $17.53 Current price: $1.36 P/L: -92.24% Sold -2.37% shares Q3 2022	share	0.07%	3.46M	$17.53	$1.36	-92.24%	Sold -2.37% shares Q3 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 2.94M Avg. open price: $8.06 Current price: $7.69 P/L: -4.60% Bought +0.01% shares Q3 2022	share	0.06%	2.94M	$8.06	$7.69	-4.60%	Bought +0.01% shares Q3 2022
Drug Manufacturers—Specialty & Generic SCYNEXIS, Inc. Portfolio share: 0.06% Portfolio value: 2.73M Avg. open price: $5.88 Current price: $2.11 P/L: -64.14% Bought +18.87% shares Q3 2022	share	0.06%	2.73M	$5.88	$2.11	-64.14%	Bought +18.87% shares Q3 2022
SOCIAL CAP SUVRETTA HLDS CP Portfolio share: 0.04% Portfolio value: 1.96M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.04%	1.96M	N/A	N/A	N/A	N/A Q2 2021
SOCIAL CAP SUVRETTA HLDS CRP Portfolio share: 0.04% Portfolio value: 1.96M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.04%	1.96M	N/A	N/A	N/A	N/A Q2 2021
Biotechnology OncoSec Medical Incorporated Portfolio share: 0.03% Portfolio value: 1.43M Avg. open price: $6.13 Current price: $2.57 P/L: -58.09% Bought +5.18% shares Q3 2021	share	0.03%	1.43M	$6.13	$2.57	-58.09%	Bought +5.18% shares Q3 2021
Medical Devices Hyperfine, Inc. Portfolio share: 0.02% Portfolio value: 1.21M Avg. open price: N/A Current price: $0.73 P/L: N/A Sold -0.70% shares Q1 2022	share	0.02%	1.21M	N/A	$0.73	N/A	Sold -0.70% shares Q1 2022
Biotechnology AC Immune SA Portfolio share: 0.02% Portfolio value: 869K Avg. open price: $7.93 Current price: $2.42 P/L: -69.48% N/A Q3 2022	share	0.02%	869K	$7.93	$2.42	-69.48%	N/A Q3 2022
Biotechnology Reunion Neuroscience Inc. Portfolio share: 0.02% Portfolio value: 851K Avg. open price: N/A Current price: $1.31 P/L: N/A N/A Q3 2022	share	0.02%	851K	N/A	$1.31	N/A	N/A Q3 2022
Health Information Services Sema4 Holdings Corp. Portfolio share: 0.02% Portfolio value: 834K Avg. open price: N/A Current price: $0.38 P/L: N/A Sold -42.77% shares Q4 2021	share	0.02%	834K	N/A	$0.38	N/A	Sold -42.77% shares Q4 2021
Biotechnology PhaseBio Pharmaceuticals, Inc. Portfolio share: 0.02% Portfolio value: 768K Avg. open price: $3.66 Current price: $0.07 P/L: -98.08% Sold -0.99% shares Q3 2022	share	0.02%	768K	$3.66	$0.07	-98.08%	Sold -0.99% shares Q3 2022
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.01% Portfolio value: 692K Avg. open price: $12.76 Current price: $0.61 P/L: -95.22% Bought +9.14% shares Q1 2022	share	0.01%	692K	$12.76	$0.61	-95.22%	Bought +9.14% shares Q1 2022
NUVATION BIO INC Portfolio share: 0.00% Portfolio value: 18K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.00%	18K	N/A	N/A	N/A	N/A Q1 2021
Drug Manufacturers—General Johnson & Johnson Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $177.23 Current price: $178.78 P/L: +0.87% Sold -100.00% shares Q3 2022	share	0.00%	0	$177.23	$178.78	+0.87%	Sold -100.00% shares Q3 2022
ARK Genomic Revolution ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $31.5 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$31.5	N/A	Sold -100.00% shares Q3 2022
Software—Infrastructure SentinelOne, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $53.57 Current price: $14.25 P/L: -73.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$53.57	$14.25	-73.40%	Sold -100.00% shares Q3 2022
Biotechnology Vir Biotechnology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $45.29 Current price: $26.57 P/L: -41.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$45.29	$26.57	-41.34%	Sold -100.00% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $46.17 Current price: $50.99 P/L: +10.43% Sold -100.00% shares Q3 2022	share	0.00%	0	$46.17	$50.99	+10.43%	Sold -100.00% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $504.43 Current price: $535.04 P/L: +6.07% Sold -100.00% shares Q3 2022	share	0.00%	0	$504.43	$535.04	+6.07%	Sold -100.00% shares Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $306.13 Current price: $382.44 P/L: +24.93% Sold -100.00% shares Q3 2022	share	0.00%	0	$306.13	$382.44	+24.93%	Sold -100.00% shares Q3 2022
Biotechnology Nuvation Bio Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.95 Current price: $1.94 P/L: -80.49% Sold -100.00% shares Q3 2022	share	0.00%	0	$9.95	$1.94	-80.49%	Sold -100.00% shares Q3 2022
Medicus Sciences Acquisition Corp. Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: $0.09 P/L: N/A N/A Q2 2021	share	0.00%	1K	N/A	$0.09	N/A	N/A Q2 2021
Drug Manufacturers—General AbbVie Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $87.13 Current price: $163.96 P/L: +88.17% Sold -100.00% shares Q3 2022	share	0.00%	0	$87.13	$163.96	+88.17%	Sold -100.00% shares Q3 2022
Shell Companies Social Capital Suvretta Holdings Corp. I Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $14.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$14.07	N/A	Sold -100.00% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.41 Current price: $21.89 P/L: +91.79% Sold -100.00% shares Q3 2022	share	0.00%	0	$11.41	$21.89	+91.79%	Sold -100.00% shares Q3 2022
SOCIAL CAP SUVRETTA HLD CRPI Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.13 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.13	N/A	Sold -100.00% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$38.83	N/A	Sold -100.00% shares Q3 2022
Medical Care Facilities Field Trip Health Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.84 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.84	N/A	Sold -100.00% shares Q3 2022

Showing TOP 112 AVIDITY PARTNERS MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of AVIDITY PARTNERS MANAGEMENT LP?

The biggest position of the AVIDITY PARTNERS MANAGEMENT LP is Eli Lilly and Company (LLY) with 6.62% portfolio share worth of 325.61M US dollars.

Top 5 AVIDITY PARTNERS MANAGEMENT LP's holdings represent 25.22% of the portfolio:

Eli Lilly and Company (LLY) – 6.62%
SPDR SER TR () – 6.53%
United Therapeutics Corporation (UTHR) – 4.13%
Neurocrine Biosciences, Inc. (NBIX) – 4.01%
Arvinas, Inc. (ARVN) – 3.93%

Who is the portfolio manager of AVIDITY PARTNERS MANAGEMENT LP?

The portfolio manager of the AVIDITY PARTNERS MANAGEMENT LP is .

What is the total asset value of the AVIDITY PARTNERS MANAGEMENT LP portfolio?

AVIDITY PARTNERS MANAGEMENT LP total asset value (portfolio value) is 4.92B US dollars.

Who is ?

is the portfolio manager of the AVIDITY PARTNERS MANAGEMENT LP.

What is (AVIDITY PARTNERS MANAGEMENT LP) fund performance?

AVIDITY PARTNERS MANAGEMENT LP's quarterly performance is -3.15%, annualy -30.40%.

What is the AVIDITY PARTNERS MANAGEMENT LP CIK?

AVIDITY PARTNERS MANAGEMENT LP's Central Index Key is 0001791827 .